Acute Myeloid Leukaemia (AML)

Overview of AML.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
HaematologyOncology

Clinical Guidelines

ESMO Clinical Practice Guideline: Acute Myeloid Leukaemia
National
NICE guideline [TA979]: Ivosidenib with azacitidine for untreated acute myeloid leukaemia
National
Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Local
Acute Myeloid Leukemia Treatment (PDQ®) – Health Professional Version
Local
American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults
Local
ESMO Clinical Practice Guideline: Acute Myeloid Leukaemia
Local
NCCN Clinical Practice Guidelines in Oncology: Acute Myeloid Leukemia
Local
PROFESSIONAL GUIDELINES FOR CLINICAL CYTOGENETICS: Best Practice Guidelines for the Analysis of Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndromes (MDS)
Local
Recommendations for laboratory testing of UK patients with acute myeloid leukaemia: a British Society for Haematology Good Practice Paper
Local
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Local